Other languages Shield Therapeutics plc

Equities

Market Closed - London S.E. Other stock markets 11:35:08 2024-05-01 EDT			5-day change	1st Jan Change
1.75 ^GBX	+29.63%		+22.81%	-73.88%

04-30	EARNINGS AND TRADING: Software Circle & Beximco report higher revenue	AN
02-22	Transcript : Shield Therapeutics plc, 2023 Sales/ Trading Statement Call, Feb 22, 2024

FTSE 100 takes hit ahead of FOMC minutes	02-21
Shield Therapeutics sinks as strong performance marred by data issues	02-21
Shield Therapeutics hires former Akili leader as new CFO	01-09
Shield Therapeutics Names New CFO	01-09
Comptoir opens restaurant; Intercede wins contract	12-07
Shield Therapeutics Chief Financial Officer Rudolf to leave	23-10-12
AIM WINNERS & LOSERS: Windward sees high contracting activity levels	23-10-12
Shield Therapeutics CFO to Step Down	23-10-12
Aston Martin CEO ups stake; Alkemy's lithium deal	23-10-03
Shield Therapeutics completes USD20 million SWK financing	23-10-03
Shield Therapeutics Closes $20 Million Debt Facility with SWK Funding	23-10-03
EARNINGS AND TRADING: Kingswood cuts outlook; Poolbeg in patent joy	23-10-02
Shield Therapeutics Raises $6 Million via Share Issue	23-09-29
Shield Therapeutics completes GBP5 million share placing	23-09-28
Shield Therapeutics raises funds for US sales push as loss narrows	23-09-28
Earnings Flash (STX.L) SHIELD THERAPEUTICS Posts H1 Revenue $4.3M	23-09-28
Shield Therapeutics plc Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-28
Shield Therapeutics changes reporting currency to US dollars	23-09-06
Shield Therapeutics prescription orders up in first quarter	23-07-20
Shield Therapeutics plc Auditor Raises 'Going Concern' Doubt	23-05-18

No results for this search